IU Simon Comprehensive Cancer Center

This month’s Simon Says Expert Series session—Earlier detection, better outcomes: A conversation on prostate cancer—will be at 12 p.m. ET Tuesday, June 23. Submit your questions and register now: https://ow.ly/wtGy50ZcPsP.

Prostate cancer is one of the most common cancers among men, but when found early, it is highly treatable. What are the signs? Who should be screened? And how can early detection make a difference?

In this Simon Says session, Clint Bahler, MD, a urologist and prostate cancer researcher, leads a conversation on prevention, screening, and early diagnosis. He’ll be joined by moderator Gene Wurth, a grateful patient, who brings a personal perspective to the discussion.

Together, they’ll share what every man should know about prostate health and what partners, family members, and caregivers can do to encourage screening and support early action. Whether you’re thinking about your own health or someone you love, this session offers practical insights during Men’s Health Month.

For 10 years, the Cell, Molecular and Cancer Biology (CMCB) graduate program has helped prepare the next generation of cancer researchers.

The program was established with leadership from Claire Walczak, PhD, and continues under the direction of Heather O’Hagan, PhD. Along with Richard Carpenter, PhD, these cancer center researchers are among the faculty mentors helping students conduct research that explores how cancer develops, progresses and responds to treatment.

Read how the program is helping train the next generation of cancer researchers: https://ow.ly/NY5250Z7Qie.

All are welcome at our Breast Cancer Science Social on Thursday, July 9. RSVP and bring a friend for an exclusive look at what our physician-scientists are doing at the Vera Bradley Foundation Center for Breast Cancer Research.

Guests will have the opportunity to meet with researchers and community partners, tour laboratory spaces and attend informational panels.

Free and open to the public.

Register now: https://ow.ly/9Y0850YZcip.

Attaya Suvannasankha, MD, a nationally recognized leader in multiple myeloma research, has been named the Harry and Edith Gladstein Professor of Cancer Research at Indiana University School of Medicine.

Dr. Suvannasankha advances immunotherapy research for patients with relapsed multiple myeloma, including leading a first in-human clinical trial that showed a 90.5% response rate in heavily pretreated patients.

Established through the generosity of the Gladstein family, this named professorship advances ongoing cancer research and supports the discovery of better treatments.

Please join us in congratulating Dr. Suvannasankha on this well-earned honor.

A major honor for one of Indiana University's research leaders.

The cancer center’s Reuben Kapur, PhD, has been named an IU Indianapolis Chancellor’s Professor.

This distinction is the highest faculty appointment at IU Indianapolis and recognizes excellence in research, teaching and service.

Read more about Dr. Kapur’s recognition and contributions to advancing science and discovery: https://ow.ly/PCfJ50Z4JvU.

Nabil Adra, MD, has been named the Rikki and Leonard Goldstein Scholar in Cancer Research at Indiana University School of Medicine.

Dr. Adra focuses on urologic oncology, treating prostate, testicular, bladder and kidney cancers. He contributed to a multi-year clinical trial that led to FDA approval of a new combination therapy, offering the potential to cure more patients with bladder cancer.

This professorship honors the legacy of Rikki and Leonard “Len” Goldstein, whose longtime support of Indiana University continues to advance cancer research and expand treatment options for patients.

Please join us in congratulating Dr. Adra on this recognition.

In an interview with NBC News, Kelvin Lee, MD, director of the cancer center, emphasized the importance of continued research to better understand how GLP-1 receptors on tumor cells may influence cancer spread and treatment response.

Learn more: https://ow.ly/g1PC50Z5lsc.

Our End Lung Cancer Now team was proud to walk alongside Indiana’s first and only mobile lung screening unit at the Indy 500 Parade—helping raise awareness for lung cancer screening and early detection.

The mobile screening program, a partnership between the IU Simon Comprehensive Cancer Center and IU Health, continues to bring screening closer to home, making it easier for more Hoosiers to take that important step for their health.

Learn more about lung cancer screening: https://ow.ly/UsJu50YUIvT.

Access to health information shouldn't depend on where you live.

In this episode of Stamats' “Did I Say That Out Loud?,” MacKenzie White, executive director of End Lung Cancer Now, an initiative of the cancer center, shares how her team is working to reach rural communities with lung cancer screening, education and resources. She also discusses why this work matters right now and how partnerships are making a difference.

Listen to the full conversation: https://ow.ly/4kiw50Z37JY.

Don't brush it off as "just a mole."

Skin cancer can show up as small changes—like a new spot, a sore that won't heal or a mole that looks different. Checking your skin regularly can help catch it early, when treatment is more effective.

Know your skin. If something changes, get it checked.

Learn more about how you can protect your health: https://ow.ly/i5nO50YNa6S.